Long COVID Affected 17 Million in Europe in First Two Years of Pandemic 13/09/2022 Rossella Tercatin TEL AVIV – When Belgian Ann Li got sick with COVID in March 2020, she did not know that the disease would follow her for years. “Even though I’m standing here in front of you looking seemingly healthy, I still suffer the consequences of the initial infection,” she told the audience of a panel devoted […] Continue reading -> COVID Threatens Meningitis Fight in Africa 09/09/2022 Paul Adepoju & John Heilprin The COVID-19 pandemic delayed plans to vaccinate more than 50 million African children with doses of MenAfriVac, a vaccine designed for the African meningitis belt. That could undo the progress in controlling a lethal form of meningitis in Africa, the World Health Organization warns. Until 12 years ago, meningitis type A made up 90% of […] Continue reading -> China Maintains “zero-COVID” Policy in Chengdu Despite Fatal 6.8 Magnitude Earthquake 07/09/2022 Raisa Santos Authorities in China’s southwestern city of Chengdu are sticking to the nation’s “zero-COVID” policy demanding a lockdown on the city’s 21 million inhabitants even in the face of a major earthquake that has killed at least 66 people in the region. Chengdu, the capital of China’s Sichuan province, has been beset by a heatwave and […] Continue reading -> WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Threatens Meningitis Fight in Africa 09/09/2022 Paul Adepoju & John Heilprin The COVID-19 pandemic delayed plans to vaccinate more than 50 million African children with doses of MenAfriVac, a vaccine designed for the African meningitis belt. That could undo the progress in controlling a lethal form of meningitis in Africa, the World Health Organization warns. Until 12 years ago, meningitis type A made up 90% of […] Continue reading -> China Maintains “zero-COVID” Policy in Chengdu Despite Fatal 6.8 Magnitude Earthquake 07/09/2022 Raisa Santos Authorities in China’s southwestern city of Chengdu are sticking to the nation’s “zero-COVID” policy demanding a lockdown on the city’s 21 million inhabitants even in the face of a major earthquake that has killed at least 66 people in the region. Chengdu, the capital of China’s Sichuan province, has been beset by a heatwave and […] Continue reading -> WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China Maintains “zero-COVID” Policy in Chengdu Despite Fatal 6.8 Magnitude Earthquake 07/09/2022 Raisa Santos Authorities in China’s southwestern city of Chengdu are sticking to the nation’s “zero-COVID” policy demanding a lockdown on the city’s 21 million inhabitants even in the face of a major earthquake that has killed at least 66 people in the region. Chengdu, the capital of China’s Sichuan province, has been beset by a heatwave and […] Continue reading -> WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Bans on Family Visits, Health Worker Burnout and Misinformation Undermined Patient Safety During COVID-19 09/08/2022 Kerry Cullinan Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy